Back
Bio-Rad Laboratories Quote, Financials, Valuation and Earnings
Sell
24
BIO.B
Bio-Rad Laboratories
Last Price:
279.91
Seasonality Move:
3.64%
7 Day Trial
ALL ACCESS PASS
$
7
Bio-Rad Laboratories Price Quote
$279.91
Bio-Rad Laboratories Key Stats
Sell
24
Bio-Rad Laboratories (BIO.B)
is a Sell
Day range:
$279.91 - $279.91
52-week range:
$271.00 - $387.55
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.11
P/B ratio:
0.88%
Volume:
0
Avg. volume:
30
1-year change:
-25.14%
Market cap:
$8B
Revenue:
$2.7B
EPS:
$-10.36
How Much Does Bio-Rad Laboratories Make?
-
How Much Are Bio-Rad Laboratories's Sales Annually?
BIO.B Revenues are $2.7B -
How Much Profit Does Bio-Rad Laboratories's Make A Year?
BIO.B net income is -$637.3M
Is Bio-Rad Laboratories Growing As A Company?
-
What Is Bio-Rad Laboratories's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.1% -
What Is Bio-Rad Laboratories's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 4.8%
Bio-Rad Laboratories Stock Price Performance
-
Did Bio-Rad Laboratories Stock Go Up Last Month?
Bio-Rad Laboratories share price went down by -17.32% last month -
Did BIO.B's Share Price Rise Over The Last Year?
BIO.B share price fell by -25.14% over the past 1 year
What Is Bio-Rad Laboratories 52-Week High & Low?
-
What Is Bio-Rad Laboratories’s 52-Week High Share Price?
Bio-Rad Laboratories has traded as high as $387.55 over the past 52 weeks -
What Is Bio-Rad Laboratories’s 52-Week Low Share Price?
Bio-Rad Laboratories has traded as low as $271.00 over the past 52 weeks
Bio-Rad Laboratories Price To Free Cash Flow
-
Is Bio-Rad Laboratories Stock Overvalued?
Bio-Rad Laboratories is trading at a price to free cash flow ratio of 43.73 -
Is Bio-Rad Laboratories Stock Undervalued?
Bio-Rad Laboratories EV to Free Cash Flow ratio is 40.59 -
What Is Bio-Rad Laboratories’s Price Earnings Growth Ratio?
BIO.B PEG ratio is -0.44 -
Is Bio-Rad Laboratories Trading At A Premium To Earnings?
Bio-Rad Laboratories EV to EBIT ratio is 0.00
Is It Risky To Buy Bio-Rad Laboratories?
-
How Much Debt Does Bio-Rad Laboratories Have?
Total long term debt quarterly is $1.2B -
How Much Cash Does Bio-Rad Laboratories Have?
Cash and short term investments quarterly total is $1.6B -
What Is Bio-Rad Laboratories’s Book Value Per Share?
Book value per share is 317.32
Is Bio-Rad Laboratories Cash Flow Positive?
-
What Is BIO.B Cash Flow From Operations?
Cash flow from operations (TTM) is $346.6M -
What Is Bio-Rad Laboratories’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$429.9M -
What Is Bio-Rad Laboratories’s Cash Flow From Investing?
Cash flow from investing (TTM) is $47.6M
Bio-Rad Laboratories Return On Invested Capital
-
Is Management Doing A Good Job?
BIO.B return on invested capital is -3.2% -
What Is Bio-Rad Laboratories Return On Assets?
ROA measures how assets are converting to revenues and is -2.58% -
What Is BIO.B Return On Equity?
ROE is a measure of profitability and is -3.63%
Bio-Rad Laboratories Earnings Date & Stock Price
-
What Is Bio-Rad Laboratories's Stock Price Today?
A single share of BIO.B can be purchased today for 279.91 -
What Is Bio-Rad Laboratories’s Stock Symbol?
Bio-Rad Laboratories trades on the nyse under the ticker symbol: BIO.B -
When Is Bio-Rad Laboratories’s Next Earnings Date?
The next quarterly earnings date for Bio-Rad Laboratories is scheduled on August 2, 2024 -
When Is BIO.B's next ex-dividend date?
Bio-Rad Laboratories's next ex-dividend date is May 18, 2024 -
How To Buy Bio-Rad Laboratories Stock?
You can buy Bio-Rad Laboratories shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Bio-Rad Laboratories Competitors
-
Who Are Bio-Rad Laboratories's Competitors?
Below is a list of companies who compete with Bio-Rad Laboratories or are related in some way:
Bio-Rad Laboratories Dividend Yield
Data Unavailable
Bio-Rad Laboratories Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 479.74% | 0% |
| Revenue: | -9.76% | -1.5% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 400.00 |
| Upside from Last Price: | 42.9% |